Teckro provides a software platform designed to make clinical trials more efficient and collaborative by digitizing trial operations and using machine learning to improve speed and accuracy. The product aims to centralize site and patient interactions, reduce reliance on paper and retrospective data, and remove friction for busy research staff. The company says its tools give research sites instant access to critical trial information and seek to increase physician participation in clinical research. Teckro reports users in more than 80 countries (up from 30 at its Series B) and employs more than 100 staff across headquarters in Limerick, an engineering hub in Dublin, and a U.S. base in Nashville. Its stated vision is to build a new digital infrastructure and toolset to make trials simpler, more transparent, and more inclusive so effective drugs move from lab to patient more efficiently. Teckro develops an information-retrieval, machine-learning platform designed to help pharmaceutical companies speed up and improve the accuracy of clinical trials. The company’s technology focuses on surfacing relevant clinical information to reduce delays and errors in trial execution. Teckro plans to use its new funding to continue platform development and to expand its operations. The firm was co-founded by Gary Hughes, Jacek Skrzypiec and Nigel Hughes in 2015. Its product targets complex-disease research where faster, more accurate trials can accelerate treatments to market. The articles do not disclose revenue or user metrics. Teckro develops a mobile software platform for clinical trials. The platform leverages information retrieval and machine learning to simplify clinical development and improve the speed and accuracy of trial conduct. Teckro partners with pharmaceutical and biotech companies and research institutions, and its technology has been adopted by a number of pharmaceutical companies. The company was co-founded in June 2015 by Gary Hughes, Jacek Skryzpiec and Nigel Hughes and is based in Limerick, Ireland. In September 2016 it raised $6M in a Series A round, bringing total funding to $7.8M, and intends to use the capital to further develop and expand its platform.

Total raised

$41M

Funding rounds

3

Latest round

Series C

Latest activity

Feb 2019